Aspire Biopharma Holdings Management
Management criteria checks 1/4
Aspire Biopharma Holdings' CEO is Kraig Higginson, appointed in Sep 2021, has a tenure of 3.67 years. directly owns 12.62% of the company’s shares, worth $1.48M. The average tenure of the management team and the board of directors is 3.7 years and 1.8 years respectively.
Key information
Kraig Higginson
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 3.7yrs |
| CEO ownership | 12.6% |
| Management average tenure | 3.7yrs |
| Board average tenure | 1.8yrs |
Recent management updates
No updates
Recent updates
CEO
Kraig Higginson (68 yo)
Mr. Kraig T. Higginson is the Founder of Raser Technologies, Inc. (former name Wasatch Web Advisors Inc.) and served as its Executive Chairman from October 2003 to November 2010. He serves as President at...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 3.7yrs | no data | 12.62% $ 1.5m | |
| Chief Financial Officer | 2.8yrs | no data | 1.15% $ 134.8k | |
| General Counsel & Corporate Secretary | 3.7yrs | no data | no data |
Experienced Management: ASBP's management team is considered experienced (3.7 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 3.7yrs | no data | 12.62% $ 1.5m | |
| Independent Director | less than a year | no data | 0.010% $ 1.2k | |
| Director | less than a year | no data | 8.83% $ 1.0m | |
| Independent Director | less than a year | no data | no data | |
| Independent Director | less than a year | no data | no data | |
| Member of Medical Advisory Board | 1.8yrs | no data | no data | |
| Director & Member of Medical Advisory Board | 6.3yrs | no data | 0.25% $ 30.0k | |
| Member of Medical Advisory Board | 2.6yrs | no data | no data | |
| Member of Medical Advisory Board | 2.9yrs | no data | no data | |
| Member of Medical Advisory Board | 1.8yrs | no data | no data | |
| Director | less than a year | no data | 0.25% $ 30.0k |
Experienced Board: ASBP's board of directors are not considered experienced ( 1.8 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/21 06:40 |
| End of Day Share Price | 2025/05/21 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Aspire Biopharma Holdings, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.